Drexel University

Alisa Morss Clyne

Lin Han

Jeffrey Krystek

Lanziye He

Sabah Shafi

Momtaz Alhindi

Mingkun Wang

Victor Micucci

Chunxiao Cui

Li-Hsin Han

Evan Ostrow

Alexander Fridman

Gennady Friedman

Sameer Kalghatgi

In one embodiment, the present invention is a method for producing microfibers comprising the steps of: (a) providing a base material; (b) forming the base material in a ring; (c) gripping opposing ends of the ring; (d) flipping one of the opposing ends relative to the other of the opposing ends, forming an upper portion and a lower portion; (e) folding the upper portion onto the lower portion; (f) stretching the folded upper and lower portions; and (g) repeating steps (d)-(f) as desired.

Method to produce micro and nanofibers with controlled diameter and large yield

A method for producing microfibers includes the steps of (a) providing a base material; (b) forming the base material in a ring; (c) gripping opposing ends of the ring; (d) flipping one of the opposing ends relative to the other of the opposing ends, forming an upper portion and a lower portion; (e) folding the upper portion onto the lower portion; (f) stretching the folded upper and lower portions; and repeating steps (d)-(f) as desired. Different apparatuses for performing the method are also provided.

Aspects of the present invention are related to methods comprising contacting an endothelial cell in an endothelial cell population with a non-thermal plasma to release an angiogenic growth factor. The released angiogenic growth factor may induce endothelial cell proliferation. In certain embodiments, the angiogenic growth factor is fibroblast growth factor-2. Preferably, the non-thermal plasma may be an atmospheric pressure dielectric barrier discharge. Additional aspects of the present invention are directed to methods for treating a disease comprising promoting angiogenesis by contacting an endothelial cell in a endothelial cell population with a non-thermal plasma to release an angiogenic growth factor. The angiogenic growth factor may induce endothelial cell proliferation. Further aspects of the present invention are directed to methods for treating a disease comprising inhibiting angiogenesis by contacting an endothelial cell in a endothelial cell population with a non-thermal plasma to reduce the number of endothelial cells in the population.

Plasma treatment for growth factor release from cells and tissues

Growing community of inventors

Ardmore, PA, United States of America

Alisa Morss Clyne